Cancer research
Researchers at Guangzhou Medical University have made a significant discovery in the field of colon cancer research, finding a novel approach to treat the disease by targeting fibroblast-activation protein (FAP) to provoke colorectal cancer immunity through photodynamic therapy. The study, published in Advanced Functional Materials, reveals that fibroblasts, a type
Cancer
Research published in Discover Oncology has shed light on the potential of metal-organic frameworks (MOFs) in cancer treatment. The study, conducted by a team of researchers from Tianjin Medical University General Hospital, analyzed 1955 papers on MOFs in cancer research, published in 327 journals between 2009 and 2023. The findings
Cancer research
A recent study published in Pediatric Blood & Cancer has investigated the incidence and risk factors of bloodstream infection (BSI) and invasive fungal infection (IFI) in pediatric acute myeloid leukemia (pAML) patients treated according to various protocols between 1998 and 2014. The study found that the cumulative incidence of any
Cancer
Vivian Campbell, guitarist of the band Def Leppard, was diagnosed with Hodgkin's lymphoma in 2013 and has been battling the disease for over a decade. After undergoing various treatments, including immunotherapy, Campbell finally achieved remission after a successful bone marrow transplant in 2022. In an interview with SiriusXM&
Cancer research
Research conducted at the General Hospital of Northern Theatre Command has shed light on the role of miR-1246 in the development of chemo-resistance in non-small cell lung cancer (NSCLC). The study found that miR-1246 levels were significantly higher in polyploid giant cancer cells (PGCCs) than in the original cells, leading
Cancer
A new study published in the Annals of Gastroenterological Surgery has highlighted significant progress in the treatment of gastric cancer, a major global health burden, particularly in East Asia. Researchers at the University of Yamanashi have summarized key updates from 2023 to 2024, focusing on surgical innovations, perioperative systemic therapy,
Cancer
Research from Sun Yat-sen University has led to the development of a double-lock protected PtII nanomedicine that has shown significant potential in treating cancer. This breakthrough has been achieved by creating a nanomedicine that releases active platinum species only in the presence of cancer cells, thereby minimizing side effects and
Cancer research
The annual meeting of the American Society of Clinical Oncology (ASCO) brought together over 35,000 participants to discuss the latest advances in cancer research. The conference featured presentations on novel targeted therapies, improvements in chemotherapy and radiation therapy approaches, and exciting new findings in the field of cancer research.
Cancer research
A recent study has shed light on the cost-effectiveness of chemotherapy and immunotherapy-based regimens for advanced and recurrent endometrial cancer. Researchers from Fujinomiya City General Hospital in Shizuoka, Japan, conducted a literature review of peer-reviewed studies from 2021 to 2025 to evaluate the incremental cost-effectiveness ratios (ICERs) of combining immune
Cancer research
Researchers from the Mayo Clinic have made a significant breakthrough in the treatment of stage 3 colon cancer, a disease that is the third most prevalent form of cancer in the U.S. According to recent research, adding immunotherapy to chemotherapy after surgery for patients with a specific genetic makeup
Cancer
Scientists at the University of Texas Austin have made a significant breakthrough in cancer therapy with the development of a new generation of drug delivery systems. These systems, designed to respond to the unique conditions of the tumor microenvironment, have the potential to revolutionize the treatment of cancer. According to
Cancer
A study published online in the International Journal of Gynecological Cancer has shown that dostarlimab plus carboplatin-paclitaxel treatment is associated with improved survival and maintenance of quality of life for patients with advanced or recurrent endometrial cancer. The research, led by Dana M. Chase, M.D., from the David Geffen
